Drug Makers Sue Trump Admin Over Drug Ad Price Disclosure Rule

By Rachel Cohrs / June 14, 2019 at 6:44 PM
Amgen, Merck and Eli Lilly on Friday (June 14) filed a lawsuit to block the Trump administration from forcing drug makers to disclose drug prices in advertisements. The drug makers argue that CMS does not have authority over drug ads and that forcing price disclosures violates the companies’ First Amendment rights. A trade group for marketers joined the drug makers in the complaint. The rule takes effect July 9. The drug makers and the Association of National Advertisers filed suit...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.